September 7, 2023
BlueWhale Bio Science Team led by world-renowned immunotherapy pioneers Carl June and James Riley of University of Pennsylvania BlueWhale Bio technology platform aims to bring cell and gene therapy benefits to patients faster and at lower cost Investors include Danaher Ventures, Novalis LifeSciences, Marshall Wace, Hillhouse Capital PHILADELPHIA -- BlueWhale Bio, Inc., a new company spun out of the University of Pennsylvania to [...]
Biosero Appoints Ryan Bernhardt as Chief Executive Officer
September 7, 2023
SAN DIEGO-- Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Ryan Bernhardt to the position of Chief Executive Officer. Mr. Bernhardt previously served as the company’s Chief Commercial Officer. Tom Gilman, Biosero’s founding CEO and president, will work closely with Mr. Bernhardt through September 30, 2023 to transition [...]
September 7, 2023
WALTHAM, Mass.-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organization, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC). The collaboration supports biopharmaceutical and [...]
September 7, 2023
Macrogen, Inc., Propath UK, and Sirona Dx Add CosMx Spatial Molecular Imager to Meet Growing Demand for Spatial Biology Tools for Drug Developers SEATTLE-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, [...]
BioFlyte Appoints Daniel Gussin as Vice President of Product
September 6, 2023
Gussin brings over 20 years of innovation and product development expertise within diagnostics and life sciences to spearhead BioFlyte’s product roadmap and commercialization efforts ALBUQUERQUE, N.M.— BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced the appointment of Daniel (Dan) Gussin as Vice President [...]
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
September 6, 2023
FARMINGDALE, NY -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he [...]
September 6, 2023
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including Brazil in the exclusive collaboration and distribution agreement for Devyser's post-transplant portfolio of NGS products. In addition to North America and Europe, Thermo Fisher will now exclusively market and sell Devyser's transplantation products under combined brands also in Brazil. "We are very [...]
Euformatics partners with Cerba to provide software tools for clinical genomic data analysis
September 6, 2023
Espoo, Finland. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has signed a new commercial relationship with Cerba, world reference laboratory in specialized clinical pathology. As part of the collaboration, Euformatics delivers the full Genomics Hub software suite to Cerba to power their NGS test validation, continuous quality [...]
September 6, 2023
Business momentum propelled by U.S. and international expansion SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced it has exceeded 100 orders of the AVITI System. With U.S. and international customers in 13 countries, Element has expanded its commercial team [...]
LumaCyte Accelerates Global Growth, Closing Strategic Series B Financing
September 6, 2023
CHARLOTTESVILLE, Va. --LumaCyte, an advanced bioanalytical instrumentation leader for rapid label-free cellular analytics, today announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand. The financing was led by Malvern Panalytical, an international leader in advanced scientific [...]

